Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension

拉坦前列素 医学 眼压 高眼压 青光眼 地塞米松 眼科 曲伏前列素 小梁网 内科学
作者
Gavin W. Roddy,Uttio Roy Chowdhury,Kjersten J. Monson,Michael P. Fautsch
出处
期刊:Current Eye Research [Taylor & Francis]
卷期号:46 (10): 1525-1530 被引量:3
标识
DOI:10.1080/02713683.2021.1899246
摘要

Purpose/Aim: Glaucomatous optic neuropathy (GON) remains the world’s leading cause of irreversible blindness. Treatments including topical medications are directed at reducing intraocular pressure (IOP), the most significant risk factor for GON. Current medications, while generally effective, are limited by insufficient response and side-effects in some patients. In search of a more targeted therapy that acts downstream of existing medications that has a potential for a lower side effect profile, our laboratory has identified Stanniocalcin-1 (STC-1), a multifunctional hormone, as an effector molecule in latanoprost-mediated IOP reduction with similar IOP-lowering efficacy as latanoprost in normotensive mice.Materials and methods: To investigate whether STC-1 can also reduce IOP in ocular hypertensive mice, we used a steroid-induced ocular hypertensive mouse model characterized by trabecular meshwork dysfunction as well as the DBA/2J mouse as an inherited model of pigment dispersion and secondary angle closure. Steroid-induced ocular hypertension was induced by weekly injections of dexamethasone into the conjunctival fornix of wild-type C57BL/6J mice (6–8 months old). After confirmation of the steroid response, mice were administered STC-1 or phosphate buffered saline (PBS) topically once daily for six weeks. For DBA/2J mice (14 months old), after baseline IOP measurements, mice were treated topically once daily with STC-1 or PBS for 5 days and IOP was assessed twice daily.Results: In steroid-induced ocular hypertensive mice, STC-1 lowered IOP by 26% (P < .001, week three) and maintained this level of IOP reduction throughout the remainder of the treatment period (P < .001, week six). In DBA/2J mice, STC-1 lowered IOP by 37% (P < .001).Conclusions: Together, these data show that STC-1 reduced IOP in two models of ocular hypertension with different mechanisms of outflow obstruction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
噗宝凹完成签到,获得积分10
1秒前
1秒前
1秒前
斯文败类应助壮观的翠芙采纳,获得10
1秒前
leilei完成签到,获得积分10
1秒前
Lucas应助啥也不会采纳,获得10
2秒前
2秒前
2秒前
思源应助shelly采纳,获得10
3秒前
半城微凉完成签到,获得积分10
3秒前
Ao发布了新的文献求助10
3秒前
4秒前
大美女完成签到,获得积分10
4秒前
lewis_xl完成签到,获得积分10
4秒前
joyland完成签到,获得积分10
4秒前
devin578632完成签到,获得积分10
4秒前
cdh1994应助康康星采纳,获得20
5秒前
Fox发布了新的文献求助10
5秒前
河畔发布了新的文献求助10
6秒前
吗喽完成签到,获得积分10
6秒前
6秒前
Yyan完成签到,获得积分10
6秒前
所所应助炙热的便当采纳,获得10
6秒前
7秒前
就这样发布了新的文献求助10
8秒前
西原的橙果完成签到,获得积分10
8秒前
8秒前
8秒前
深情安青应助疯狂的兰采纳,获得10
9秒前
9秒前
9秒前
跳跃的翼发布了新的文献求助30
10秒前
Lucien给伊斯坦布尔的鱼的求助进行了留言
10秒前
在下天池宫人间行走完成签到,获得积分10
11秒前
不想学习发布了新的文献求助10
11秒前
冬青完成签到 ,获得积分10
11秒前
含糊的鱼发布了新的文献求助10
11秒前
11秒前
Ansen发布了新的文献求助10
11秒前
科研通AI2S应助fu采纳,获得10
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970683
求助须知:如何正确求助?哪些是违规求助? 3515337
关于积分的说明 11178055
捐赠科研通 3250580
什么是DOI,文献DOI怎么找? 1795357
邀请新用户注册赠送积分活动 875790
科研通“疑难数据库(出版商)”最低求助积分说明 805166